나노엔텍

039860KOSDAQ의료용 기기 제조업

53.2 / 100

Reference Date: 2026-04-13

Financial Score18.0 / 40

News Sentiment19.2 / 25

Momentum6.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but PER raises overvaluation concerns. Plunged 19.3% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

NanoEntek develops, manufactures, and sells in vitro diagnostic medical devices and life science experiment equipment based on the Lab-On-a-Chip (LOC) platform. The company leverages its core Bio-MEMS technology, integrating microfluidics and nanotechnology, to enable applications in cancer diagnostics, cell counting, and other fields. It operates a U.S. sales subsidiary and a B2B healthcare service arm, expanding its global market presence.

Number of Employees

141people

Average Salary

53.2M KRW

Score Calculation Basis

Detailed Financial Score

PER

105.96Industry Average 26.520.0Point

4.0x industry avg (risky)

PBR

2.09Industry Average 1.702.5Point

Higher than industry avg (caution)

ROE

1.92Industry Average 8.001.0Point

Well below industry avg

Debt Ratio

1.76Industry Average 10.958.0Point

Half of industry avg (excellent)

Trend 2023~20256.5 / 10 points

Revenue Growth Rate

2.5 / 3

Avg ▲19.3% (2-year basis)

Operating Profit Growth Rate

3.0 / 3

Avg ▲102.6% (2-year basis)

ROE Trend

1.0 / 4

Avg ROE 0.3% (improving, 3yr)

Detailed News Sentiment

3 totalPositive 2Neutral 0Negative 0Average Sentiment Score 90

Positive
나노엔텍, 작년 영업익 전년비 77.4%↑...“바이오로봇·로레알 등 ...
나노엔텍이 작년 영업이익이 전년 대비 77.4% 증가하고 매출액이 25.1% 성장하며 두 자릿수 성장세를 기록했습니다.
Positive
나노엔텍, 지난해 영업이익 11억…전년比 77.4%↑
나노엔텍이 지난해 영업이익 11억원을 기록하며 전년 대비 77.4% 증가했습니다.

Detailed Momentum

52-week position5.0Point

52w mid range (42%)

Current 4,980Won52-week high 7,67052-week low 3,030

1-month return0.0Point

1m -19.29% (strong drop)

Volume trend1.0Point

Volume dry-up

Detailed Disclosure

8 totalPositive 0Neutral 8Negative 0

Neutral정기주주총회결과2026-03-31
Neutral사업보고서 (2025.12)2026-03-23
Neutral주식등의대량보유상황보고서(일반)2026-03-20
Neutral감사보고서제출2026-03-20
Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-03-20